In patients with stage II-III rectal cancer, non-operative management after a clinical complete response to neoadjuvant ...
TipRanks on MSN
Incyte steps into late-stage colorectal cancer race with new phase 3 trial of INCA33890
Incyte ($INCY) announced an update on their ongoing clinical study. Study Overview Incyte’s new Phase 3 trial, titled “A Randomized, Double-Blind, ...
Five years after being diagnosed with stage 4 colorectal cancer at 28, Joe Faratzis is reflecting on the six red flags that signaled he was struggling with a serious disease. “I put these symptoms off ...
James Van Der Beek’s stage 3 colorectal cancer fight will be documented in an upcoming interview on the “Today” show. “Today” ...
PHILADELPHIA (WPVI) -- There is a clinical trial going on that hopes to change the way patients with early-stage colorectal cancer are treated. Fox Chase Cancer Center is investigating a method ...
She was shocked to be diagnosed with rectal cancer at 29 and had her reproductive organs temporarily moved out of her pelvis ...
Although rectal cancer is a life-threatening disease, it is highly curable in its early stages. Depending on the location and state of the cancer, surgery may be required. To avoid life-altering ...
A new, highly accurate testing service that improves the early-stage detection of bowel cancer with strong clinical validity will be available in the UK within the next few weeks. The service ...
Cases of colorectal cancer in younger adults are climbing worldwide, driven by lifestyle changes and inherited genetic risks.
Oncolytics Biotech® Inc. (Nasdaq: ONCY) ("Oncolytics" or the "Company"), a clinical-stage immunotherapy company developing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results